These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26780385)

  • 21. Phytantriol based smart nano-carriers for drug delivery applications.
    Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
    Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery.
    Koynova R; Tenchov B
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):165-73. PubMed ID: 23829393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipidated polymers for the stabilization of cubosomes: nanostructured drug delivery vehicles.
    Grace JL; Alcaraz N; Truong NP; Davis TP; Boyd BJ; Quinn JF; Whittaker MR
    Chem Commun (Camb); 2017 Sep; 53(76):10552-10555. PubMed ID: 28890981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
    Zabara A; Mezzenga R
    J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cubosomes as Carriers for MRI Contrast Agents.
    Alcaraz N; Boyd BJ
    Curr Med Chem; 2017; 24(5):470-482. PubMed ID: 27538694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cubic phase gels as drug delivery systems.
    Shah JC; Sadhale Y; Chilukuri DM
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):229-50. PubMed ID: 11311994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A short review on the applicability and use of cubosomes as nanocarriers.
    Palma AS; Casadei BR; Lotierzo MC; de Castro RD; Barbosa LRS
    Biophys Rev; 2023 Aug; 15(4):553-567. PubMed ID: 37681099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications.
    Sivadasan D; Sultan MH; Alqahtani SS; Javed S
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review.
    Almoshari Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of optimum conditions for Achyranthes bidentata polysaccharides encapsulated in cubosomes and immunological activity in vitro.
    Ou N; Sun Y; Zhou S; Gu P; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Int J Biol Macromol; 2018 Apr; 109():748-760. PubMed ID: 29157913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
    Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
    J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and potential applications of nanostructured aqueous dispersions.
    Yaghmur A; Glatter O
    Adv Colloid Interface Sci; 2009; 147-148():333-42. PubMed ID: 18804754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of Nanostructured Lipid Drug Delivery Particles Using Microfluidic Mixing.
    Hong L; Dong YD; Boyd BJ
    Pharm Nanotechnol; 2019; 7(6):484-495. PubMed ID: 31584384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation.
    Lasoń E; Sikora E; Ogonowski J
    Acta Biochim Pol; 2013; 60(4):773-7. PubMed ID: 24432330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
    Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
    J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
    Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
    Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.